Department of Cell and Molecular Pharmacology and Experimental Therapeutics,
Hollings Cancer Center
Russell Spencer-Smith has not added Biography.
If you are Russell Spencer-Smith and would like to personalize this page please email our Author Liaison for assistance.
Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene Apr, 2019 | Pubmed ID: 30573767
Correction: Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene May, 2019 | Pubmed ID: 30710144
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Cell reports Feb, 2022 | Pubmed ID: 35139380
Medical University of South Carolina
National Cancer Institute-Frederick
Russell Spencer-Smith1,2,3
1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina,
2Hollings Cancer Center, Medical University of South Carolina,
3Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены